Timo Wolf, MD

MD
Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany, Germany

Disclosure(s): Gilead Sciences: Lecture fee, travel grant; Janssen Pharmaceuticals: Lecture fee, travel grant; Merck Sharp Dome: Lecture fee, travel grant

Poster(s):

• 1142 - Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET